Eliem Therapeutics, Inc. (ELYM): Price and Financial Metrics

Eliem Therapeutics, Inc. (ELYM): $4.31

0.27 (-5.90%)

POWR Rating

Component Grades

Momentum

D

Stability

C

Sentiment

Quality

D

Add ELYM to Watchlist
Sign Up

Industry: Biotech

Industry

NR

Ranked

#300 of 402

in industry

ELYM Price/Volume Stats

Current price $4.31 52-week high $4.97
Prev. close $4.58 52-week low $2.34
Day low $4.30 Volume 1,203,300
Day high $4.97 Avg. volume 603,593
50-day MA $2.77 Dividend yield N/A
200-day MA $2.71 Market Cap 119.47M

ELYM Stock Price Chart Interactive Chart >


Eliem Therapeutics, Inc. (ELYM) Company Bio


Eliem Therapeutics, Inc., a clinical-stage biotechnology company, focuses on developing novel therapies for neuronal excitability disorders to address unmet needs in chronic pain, psychiatry, epilepsy, and other disorders of the peripheral and central nervous systems in the United States. The company's lead clinical-stage candidates include ETX-810, a novel palmitoylethanolamide prodrug that is in Phase IIa clinical trials for the treatment of diabetic peripheral neuropathic pain and pain associated with lumbosacral radiculopathy; and ETX-155 is a neurosteroid GABAA receptor positive allosteric modulator for the treatment of major depressive disorder, perimenopausal depression, and focal onset seizures. Its lead preclinical program includes Kv7.2/3 potassium channel opener for epilepsy and pain; and novel analog of 2,3- benzodiazepine for the treatment of generalized anxiety disorder. The company was incorporated in 2018 and is headquartered in Redmond, Washington.


ELYM Latest News Stream


Event/Time News Detail
Loading, please wait...

ELYM Latest Social Stream


Loading social stream, please wait...

View Full ELYM Social Stream

Latest ELYM News From Around the Web

Below are the latest news stories about ELIEM THERAPEUTICS INC that investors may wish to consider to help them evaluate ELYM as an investment opportunity.

Eliem Therapeutics (NASDAQ:ELYM) Is In A Good Position To Deliver On Growth Plans

Just because a business does not make any money, does not mean that the stock will go down. For example, although...

Yahoo | September 28, 2023

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday

It's the final day of trading this week and we're starting it with a breakdown of the biggest pre-market stock movers for Friday!

William White on InvestorPlace | July 21, 2023

Eliem (ELYM) to Explore Strategic Options, Stock Rises 6%

Eliem (ELYM) announces its decision to halt its Kv7 development program in its quest to explore strategic alternatives. The stock of the company rises 6% in response on Thursday.

Yahoo | July 21, 2023

Why Is BioSig Technologies (BSGM) Stock Up 19% Today?

BioSig Technologies (BSGM) stock is rising higher on Thursday as subsidiary BioSig AI Sciences joins Nvidia's (NVDA) Inception program.

William White on InvestorPlace | July 20, 2023

Why Is Discover Financial (DFS) Stock Down 13% Today?

Discover Financial (DFS) stock is falling on Thursday after the financial services company revealed it's undergoing a regulatory review.

William White on InvestorPlace | July 20, 2023

Read More 'ELYM' Stories Here

ELYM Price Returns

1-mo 59.63%
3-mo N/A
6-mo 67.70%
1-year 36.83%
3-year N/A
5-year N/A
YTD 59.63%
2023 -26.43%
2022 -64.91%
2021 N/A
2020 N/A
2019 N/A

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!